Albany Molecular Research ($AMRI) has announced plans to close a facility in Budapest, axing 100 jobs in the process. The contract research group and manufacturer says it plans to complete a restructuring in the second quarter. Story
| Published: February 18, 2014 | Sponsored by: NextDocs
Big pharma and biotech companies have undergone a series of consolidations, as internal research budgets continue to shrink. With much more at stake, the industry is evolving to embrace more collaborative, future-thinking tools that will not only save sponsors money, but that will also increase efficiency, expedite trials and help identify ineffective drugs sooner. Download this eBrief today!